Fos-related antigen 2 (Fra-2) memorizes photoperiod in the rat pineal gland. 2005

L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
Department of Anatomy, Johannes Gutenberg University, Saarstrasse 19-21, D-55099 Mainz, Germany.

As the physiological role of fos-related antigen-2 (Fra-2) is largely unknown and since the pineal plays an important role in the photoperiodic control of the body, we have tested the hypothesis that Fra-2 expression is photoperiod-dependent and may be involved in imprinting photoperiod on the pineal gland and the body as a whole. To this end, we have investigated Fra-2 mRNA expression and Fra-2 protein expression under various light/dark (LD) cycles. A clear nocturnal increase occurs for both monitored parameters under all photoperiodic conditions studied. The level of Fra-2 protein expression clearly depends on photoperiod, because the amount of protein at dark onset and during the night negatively correlates with the length of the photoperiod. Further, high-phosphorylated Fra-2 isoforms are abundant under all photoperiods tested, with the exception of LD 20:4. Because Fra-2 phosphorylation depends on cGMP, a depressed cGMP response to adrenergic stimulation under LD 20:4 appears to explain this finding. We conclude that photoperiod is imprinted on Fra-2 in terms of both protein amount and protein phosphorylation in the rat pineal gland. This imprinting becomes fully manifest after about 7 days only, suggesting that a number of altered photoperiodic cycles are required for pineal Fra-2 to "learn" that the photoperiod has changed. Reportedly, Fra-2 limits expression of the enzyme iodothyronine deiodinase type II, which catalyzes the intracellular deiodination of thyroxine prohormone to the active 3,3',5-triiodothyronine. We have found that the extent of Fra-2 expression inversely correlates with the dII gene response to cAMP; hence the photoperiodic regulation of Fra-2 may affect the body by changing pineal thyroid hormone metabolism.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
November 1995, The Journal of biological chemistry,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
June 2001, Molecular and cellular biology,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
January 1977, Experientia,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
July 2004, The EMBO journal,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
August 2003, Oncogene,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
February 2011, Cancer biology & therapy,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
September 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
January 2011, Cancer biology & therapy,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
October 2002, Journal of neurochemistry,
L Engel, and B B P Gupta, and V Lorenzkowski, and B Heinrich, and I Schwerdtle, and S Gerhold, and H Holthues, and L Vollrath, and R Spessert
March 1995, Oncogene,
Copied contents to your clipboard!